GSEA analysis showed a significant increase of pathways involved in IgA production in mild, moderate and severe COPD cores compared with controls cores (Table 2, Figure 3C) (GSEA data analysis, Table E3). This evidence concerns the gene CD79A and chronic obstructive pulmonary disease.